Certain Class B Common Stock of LAVA Medtech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 24-APR-2022. These Class B Common Stock will be under lockup for 180 days starting from 26-OCT-2021 to 24-APR-2022.

Details:
The company's sponsor and officers and directors have agreed that, for a period of 180 days from the date of this prospectus, will not, without the prior written consent of the Representative, offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any units, warrants, shares of common stock or any other securities convertible into, or exercisable, or exchangeable for, shares of common stock, subject to certain exceptions.